These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29106686)

  • 1. The Identification of Pivotal Transcriptional Factors Mediating Cell Responses to Drugs With Drug-Induced Liver Injury Liabilities.
    Shah F; Medvedev A; Wassermann AM; Brodney M; Zhang L; Makarov S; Stanton RV
    Toxicol Sci; 2018 Mar; 162(1):177-188. PubMed ID: 29106686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the Nrf2 response by intrinsic hepatotoxic drugs correlates with suppression of NF-κB activation and sensitizes toward TNFα-induced cytotoxicity.
    Herpers B; Wink S; Fredriksson L; Di Z; Hendriks G; Vrieling H; de Bont H; van de Water B
    Arch Toxicol; 2016 May; 90(5):1163-79. PubMed ID: 26026609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput confocal imaging of differentiated 3D liver-like spheroid cellular stress response reporters for identification of drug-induced liver injury liability.
    Hiemstra S; Ramaiahgari SC; Wink S; Callegaro G; Coonen M; Meerman J; Jennen D; van den Nieuwendijk K; Dankers A; Snoeys J; de Bont H; Price L; van de Water B
    Arch Toxicol; 2019 Oct; 93(10):2895-2911. PubMed ID: 31552476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in vitro coculture system of human peripheral blood mononuclear cells with hepatocellular carcinoma-derived cells for predicting drug-induced liver injury.
    Oda S; Uchida Y; Aleo MD; Koza-Taylor PH; Matsui Y; Hizue M; Marroquin LD; Whritenour J; Uchida E; Yokoi T
    Arch Toxicol; 2021 Jan; 95(1):149-168. PubMed ID: 32816093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic imaging of adaptive stress response pathway activation for prediction of drug induced liver injury.
    Wink S; Hiemstra SW; Huppelschoten S; Klip JE; van de Water B
    Arch Toxicol; 2018 May; 92(5):1797-1814. PubMed ID: 29502165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury.
    Laifenfeld D; Qiu L; Swiss R; Park J; Macoritto M; Will Y; Younis HS; Lawton M
    Toxicol Sci; 2014 Jan; 137(1):234-48. PubMed ID: 24136188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The integrated stress response-related expression of CHOP due to mitochondrial toxicity is a warning sign for DILI liability.
    Vlasveld M; Callegaro G; Fisher C; Eakins J; Walker P; Lok S; van Oost S; de Jong B; Pellegrino-Coppola D; Burger G; Wink S; van de Water B
    Liver Int; 2024 Mar; 44(3):760-775. PubMed ID: 38217387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric assay using HepaRG cells for predicting drug-induced liver injury.
    Tomida T; Okamura H; Satsukawa M; Yokoi T; Konno Y
    Toxicol Lett; 2015 Jul; 236(1):16-24. PubMed ID: 25934330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced endoplasmic reticulum and oxidative stress responses independently sensitize toward TNFα-mediated hepatotoxicity.
    Fredriksson L; Wink S; Herpers B; Benedetti G; Hadi M; de Bont H; Groothuis G; Luijten M; Danen E; de Graauw M; Meerman J; van de Water B
    Toxicol Sci; 2014 Jul; 140(1):144-59. PubMed ID: 24752500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of temporal single cell cellular stress response activity with logic-ODE modeling reveals activation of ATF4-CHOP axis as a critical predictor of drug-induced liver injury.
    Wijaya LS; Trairatphisan P; Gabor A; Niemeijer M; Keet J; Alcalà Morera A; Snijders KE; Wink S; Yang H; Schildknecht S; Stevens JL; Bouwman P; Kamp H; Hengstler J; Beltman J; Leist M; Le Dévédec S; Saez-Rodriguez J; van de Water B
    Biochem Pharmacol; 2021 Aug; 190():114591. PubMed ID: 33957093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic activation and drug-induced liver injury: in vitro approaches for the safety risk assessment of new drugs.
    Gómez-Lechón MJ; Tolosa L; Donato MT
    J Appl Toxicol; 2016 Jun; 36(6):752-68. PubMed ID: 26691983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man.
    Dragovic S; Vermeulen NP; Gerets HH; Hewitt PG; Ingelman-Sundberg M; Park BK; Juhila S; Snoeys J; Weaver RJ
    Arch Toxicol; 2016 Dec; 90(12):2979-3003. PubMed ID: 27659300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Drug-Induced Hepatotoxicity Using Long-Term Stable Primary Hepatic 3D Spheroid Cultures in Chemically Defined Conditions.
    Vorrink SU; Zhou Y; Ingelman-Sundberg M; Lauschke VM
    Toxicol Sci; 2018 Jun; 163(2):655-665. PubMed ID: 29590495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Customised in vitro model to detect human metabolism-dependent idiosyncratic drug-induced liver injury.
    Tolosa L; Jiménez N; Pérez G; Castell JV; Gómez-Lechón MJ; Donato MT
    Arch Toxicol; 2018 Jan; 92(1):383-399. PubMed ID: 28762043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimizing DILI risk in drug discovery - A screening tool for drug candidates.
    Schadt S; Simon S; Kustermann S; Boess F; McGinnis C; Brink A; Lieven R; Fowler S; Youdim K; Ullah M; Marschmann M; Zihlmann C; Siegrist YM; Cascais AC; Di Lenarda E; Durr E; Schaub N; Ang X; Starke V; Singer T; Alvarez-Sanchez R; Roth AB; Schuler F; Funk C
    Toxicol In Vitro; 2015 Dec; 30(1 Pt B):429-37. PubMed ID: 26407524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Transcriptional Biomarkers of Xenobiotic Receptor Activation in Rat Liver for the Early Assessment of Drug Safety Liabilities.
    Podtelezhnikov AA; Monroe JJ; Aslamkhan AG; Pearson K; Qin C; Tamburino AM; Loboda AP; Glaab WE; Sistare FD; Tanis KQ
    Toxicol Sci; 2020 May; 175(1):98-112. PubMed ID: 32119089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of multiple mechanism-based toxicity endpoints in primary cultured human hepatocytes for the identification of drugs with clinical hepatotoxicity: Results from 152 marketed drugs with known liver injury profiles.
    Zhang J; Doshi U; Suzuki A; Chang CW; Borlak J; Li AP; Tong W
    Chem Biol Interact; 2016 Aug; 255():3-11. PubMed ID: 26581450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro Drug-Induced Liver Injury Prediction: Criteria Optimization of Efflux Transporter IC50 and Physicochemical Properties.
    Yucha RW; He K; Shi Q; Cai L; Nakashita Y; Xia CQ; Liao M
    Toxicol Sci; 2017 Jun; 157(2):487-499. PubMed ID: 28369588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Induced Liver Injury (DILI). Mechanisms and Medicinal Chemistry Avoidance/Mitigation Strategies.
    Norman BH
    J Med Chem; 2020 Oct; 63(20):11397-11419. PubMed ID: 32511920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HepaRG cell line, a superior in vitro model to L-02, HepG2 and hiHeps cell lines for assessing drug-induced liver injury.
    Wu Y; Geng XC; Wang JF; Miao YF; Lu YL; Li B
    Cell Biol Toxicol; 2016 Feb; 32(1):37-59. PubMed ID: 27027780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.